ZW4585A1
(en)
*
|
1984-04-19 |
1985-11-20 |
Hoffmann La Roche |
Imidazole derivatives
|
JPS6150978A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
SE8505112D0
(sv)
*
|
1985-10-29 |
1985-10-29 |
Haessle Ab |
Novel pharmacological compounds
|
NZ220022A
(en)
*
|
1986-04-22 |
1990-04-26 |
Byk Gulden Lomberg Chem Fab |
1,4-dihydropyridine derivatives and pharmaceutical compositions
|
DE3621215A1
(de)
*
|
1986-06-25 |
1988-01-07 |
Bayer Ag |
Fluorhaltige o-phenylendiamine und o-aminophenole
|
DE3855692D1
(de)
*
|
1987-07-16 |
1997-01-16 |
Byk Gulden Lomberg Chem Fab |
Imidazo[1,2-a]pyridine
|
EP0390842A1
(de)
*
|
1987-12-11 |
1990-10-10 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Neue benzimidazolderivate
|
DE4018642C2
(de)
*
|
1990-06-11 |
1993-11-25 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
|
SE9002206D0
(sv)
*
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
FR2665158B1
(fr)
*
|
1990-07-30 |
1993-12-24 |
Air Liquide |
Clathrates de peroxyacides.
|
EP0481764B1
(en)
*
|
1990-10-17 |
2000-03-29 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, their production and use
|
CA2138787A1
(en)
*
|
1992-07-08 |
1994-01-20 |
Clifton Augustus Baile |
Alleviating stomach ulcers in swine
|
EP0695123A4
(en)
*
|
1993-04-27 |
1996-09-11 |
Sepracor Inc |
METHOD AND COMPOSITIONS FOR TREATING GASTRICAL FAULTS USING OPTICALLY PURE PANTOPRAZOLS
|
AU4504000A
(en)
*
|
1993-04-27 |
2000-09-07 |
Sepracor, Inc. |
Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
|
JPH08509738A
(ja)
*
|
1993-04-27 |
1996-10-15 |
セプラコー,インコーポレイテッド |
光学的に純粋な(+)パントプラゾールを用いる胃の疾患治療の方法と組成
|
SE9301489D0
(sv)
|
1993-04-30 |
1993-04-30 |
Ab Astra |
Veterinary composition
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
TW280770B
(da)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
CN1045773C
(zh)
*
|
1994-06-23 |
1999-10-20 |
沈阳药科大学 |
吡啶衍生物的制备方法
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
GB9423968D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Resolution
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
US5708017A
(en)
*
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
DE69631981T2
(de)
*
|
1995-09-21 |
2005-04-14 |
Pharma Pass Ii Llc, Irvine |
Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
US6599927B2
(en)
|
1996-10-11 |
2003-07-29 |
Astrazeneca Ab |
Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
|
WO1998054172A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Dr. Reddy's Research Foundation |
Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
|
DE19745692A1
(de)
*
|
1997-07-24 |
1999-01-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten
|
DE69827392T2
(de)
|
1997-07-25 |
2005-10-27 |
Altana Pharma Ag |
Protonenpumpenhemmer als kombinationstherapeutika mit antibakteriell wirkenden substanzen
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
CN1195500C
(zh)
|
1998-05-18 |
2005-04-06 |
武田药品工业株式会社 |
可口腔崩解的片剂
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
IE990506A1
(en)
*
|
1998-06-26 |
2000-11-15 |
Russinsky Ltd |
Pyridine Building Blocks
|
BR9912937A
(pt)
|
1998-08-10 |
2001-05-08 |
Partnership Of Michael E Garst |
Pró-drogas de inibidores de bomba de prótons
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
ATE321538T1
(de)
|
1998-08-12 |
2006-04-15 |
Altana Pharma Ag |
Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
JP3926936B2
(ja)
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
US6362202B1
(en)
|
1999-03-02 |
2002-03-26 |
Sepracor Inc. |
Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
|
US6353005B1
(en)
|
1999-03-02 |
2002-03-05 |
Sepracor, Inc. |
Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
PT1187601E
(pt)
|
1999-06-07 |
2005-11-30 |
Altana Pharma Ag |
Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido
|
US6316020B1
(en)
*
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
SE0100823D0
(sv)
*
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method I to obtain microparticles
|
SE9903831D0
(sv)
*
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
SE0000774D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
AU2001296908A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Geneva Pharmaceuticals, Inc. |
Proton pump inhibitor formulation
|
ES2185459B1
(es)
|
2000-10-02 |
2003-12-16 |
Dinamite Dipharma Spa |
Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.
|
MY137726A
(en)
|
2000-11-22 |
2009-03-31 |
Nycomed Gmbh |
Freeze-dried pantoprazole preparation and pantoprazole injection
|
KR20030059318A
(ko)
|
2000-12-07 |
2003-07-07 |
알타나 파마 아게 |
산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
|
AU2002231654A1
(en)
|
2000-12-07 |
2002-06-18 |
Byk Gulden Lomberg Chemische Fabrik G.M.B.H. |
Pharmaceutical paste comprising an acid-labile active ingredient
|
SE0100822D0
(sv)
*
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method II to obtain microparticles
|
EP1379167A1
(en)
*
|
2001-04-06 |
2004-01-14 |
Medic4all Inc. |
A physiological monitoring system for a computational device of a human subject
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
AU2002332178B2
(en)
*
|
2001-09-18 |
2005-12-08 |
Zeria Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
FR2830447B1
(fr)
*
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
SE0104295D0
(sv)
*
|
2001-12-18 |
2001-12-18 |
Astrazeneca Ab |
New process
|
DE60325709D1
(de)
|
2002-04-09 |
2009-02-26 |
Flamel Tech Sa |
Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
|
CA2480824A1
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
CA2493618A1
(en)
*
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
DK1575941T3
(da)
|
2002-12-06 |
2012-07-09 |
Nycomed Gmbh |
Fremgangsmåde til fremstilling af (S)-pantoprazol
|
BRPI0310118B1
(pt)
|
2002-12-06 |
2015-10-20 |
Altana Pharma Ag |
processo para a preparação de inibidores de bomba de próton (ppi) opticamente puro possuindo uma estrutura de sulfinila
|
JP2006514108A
(ja)
|
2002-12-19 |
2006-04-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
|
RU2345075C2
(ru)
*
|
2003-01-15 |
2009-01-27 |
Сипла Лимитед |
Способ получения фармацевтических средств и соединения, полученные данным способом
|
ES2245277T1
(es)
*
|
2003-03-12 |
2006-01-01 |
Teva Pharmaceutical Industries Limited |
Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
|
US7608625B2
(en)
*
|
2003-03-13 |
2009-10-27 |
Eisai R & D Management Co., Ltd. |
Method for treating bruxism and bruxism-related diseases
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US7524837B2
(en)
*
|
2003-05-12 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
Benzotriazapinone salts and methods for using same
|
US7683177B2
(en)
|
2003-06-10 |
2010-03-23 |
Teva Pharmaceutical Industries Ltd |
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
BRPI0412590A
(pt)
*
|
2003-07-15 |
2006-09-19 |
Allergan Inc |
processo para preparação de pró-drogas isomericamente puras de inibidores de bomba de próton
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
CA2554260A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Altana Pharma Ag |
Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
JP2007523163A
(ja)
*
|
2004-02-18 |
2007-08-16 |
アラーガン、インコーポレイテッド |
プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
|
CA2558535A1
(en)
*
|
2004-03-03 |
2005-10-06 |
Teva Pharmaceutical Industries Ltd. |
A stable pharmaceutical composition comprising an acid labile drug
|
CA2561700A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
WO2005105799A1
(en)
*
|
2004-04-28 |
2005-11-10 |
Altana Pharma Ag |
Dialkoxy-imidazopyridines derivatives
|
CA2565083C
(en)
*
|
2004-05-07 |
2014-07-08 |
Altana Pharma Ag |
Novel pharmaceutical dosage form and manufacturing process
|
TW200613301A
(en)
*
|
2004-06-15 |
2006-05-01 |
Altana Pharma Ag |
Novel amino-halogen-imidazopyridines
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
AR052225A1
(es)
*
|
2004-11-04 |
2007-03-07 |
Astrazeneca Ab |
Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
|
AR051654A1
(es)
*
|
2004-11-04 |
2007-01-31 |
Astrazeneca Ab |
Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
|
WO2006053383A1
(en)
|
2004-11-22 |
2006-05-26 |
Anadis Ltd |
Bioactive compositions
|
ZA200706613B
(en)
|
2004-12-16 |
2009-03-25 |
Cipla Ltd |
Process
|
CA2607583A1
(en)
*
|
2005-05-06 |
2007-04-05 |
Medichem, S.A. |
Pantoprazole free acid form iii
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7601737B2
(en)
*
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
EP1747776A1
(en)
|
2005-07-29 |
2007-01-31 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmaceutical composition comprising granular pantoprazole
|
WO2007026188A1
(en)
*
|
2005-09-01 |
2007-03-08 |
Wockhardt Limited |
Process for the manufacture of antiulceratives
|
CN101309917B
(zh)
*
|
2005-10-06 |
2013-09-11 |
奥斯拜客斯制药有限公司 |
具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂
|
AR057181A1
(es)
*
|
2005-11-30 |
2007-11-21 |
Astra Ab |
Nueva forma de dosificacion de combinacion
|
GB0525710D0
(en)
*
|
2005-12-17 |
2006-01-25 |
Pliva Hrvatska D O O |
An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
WO2007074856A1
(ja)
|
2005-12-28 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
口腔内崩壊性固形製剤の製造法
|
WO2007086077A2
(en)
*
|
2006-01-24 |
2007-08-02 |
Unichem Laboratories Limited |
A novel one pot process for preparation of pantoprazole sodium sesquihydrate
|
CN101453993A
(zh)
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
US20090111856A1
(en)
*
|
2006-05-09 |
2009-04-30 |
Mikael Brulls |
Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007146341A2
(en)
|
2006-06-12 |
2007-12-21 |
Teva Pharmaceutical Industries Ltd. |
Amorphous and crystalline forms of pantoprazole magnesium salt
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
PL2046334T3
(pl)
*
|
2006-07-25 |
2015-02-27 |
Vecta Ltd |
Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
|
WO2008036201A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Alevium Pharmaceuticals, Inc. |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
WO2008067037A2
(en)
|
2006-10-05 |
2008-06-05 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
EP2086543A2
(en)
|
2006-10-27 |
2009-08-12 |
The Curators of the University of Missouri |
Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
|
US9205094B2
(en)
|
2006-12-22 |
2015-12-08 |
Ironwood Pharmaceuticals, Inc. |
Compositions comprising bile acid sequestrants for treating esophageal disorders
|
CN101631768A
(zh)
*
|
2007-03-15 |
2010-01-20 |
太阳医药高级研究有限公司 |
新型前药
|
US20100210847A1
(en)
*
|
2007-07-17 |
2010-08-19 |
Ranbaxy Laboratories Limited |
Process for the preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate
|
CN101492459B
(zh)
*
|
2008-01-25 |
2011-04-27 |
山东轩竹医药科技有限公司 |
含烷氧乙酰基二氢异噁唑并吡啶化合物
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
US20100093747A1
(en)
*
|
2008-10-10 |
2010-04-15 |
Erica Brook Goodhew |
Method of inducing negative chemotaxis
|
WO2010122583A2
(en)
|
2009-04-24 |
2010-10-28 |
Rubicon Research Private Limited |
Oral pharmaceutical compositions of acid labile substances
|
MX2012000057A
(es)
*
|
2009-06-25 |
2012-06-01 |
Pozen Inc |
Metodo para tratar a un paciente con necesidad de terapia de aspirina.
|
WO2010151216A1
(en)
|
2009-06-25 |
2010-12-29 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
EP2519229A2
(en)
|
2009-12-29 |
2012-11-07 |
Novartis AG |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
CN102140099A
(zh)
*
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9233103B2
(en)
|
2011-03-25 |
2016-01-12 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
EP2601947A1
(en)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Fixed-dose combination for treatment of helicobacter pylori associated diseases
|
KR20140113667A
(ko)
|
2011-12-16 |
2014-09-24 |
아토픽스 테라퓨릭스 리미티드 |
호산구성 식도염의 치료를 위한 crth2 길항제 및 양성자 펌프 저해제의 조합
|
CA2860231A1
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
CN104203938A
(zh)
|
2012-01-21 |
2014-12-10 |
朱比兰特生命科学有限公司 |
用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法
|
EP2945614B1
(en)
|
2013-01-15 |
2021-11-24 |
Ironwood Pharmaceuticals, Inc. |
Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
|
US20160115136A1
(en)
*
|
2013-03-13 |
2016-04-28 |
University Of Iowa Research Foundation |
Compounds, compositions comprsing same, and methods related thereto
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
CN110487918B
(zh)
*
|
2018-05-14 |
2022-02-08 |
中国医学科学院药物研究所 |
泮托拉唑钠及其起始原料中基因毒性杂质的分析方法
|
TW202126317A
(zh)
|
2019-09-24 |
2021-07-16 |
美商普拉塔生技公司 |
用於治療發炎和免疫疾病之組成物和方法
|
WO2022043468A1
(en)
|
2020-08-26 |
2022-03-03 |
Syngenta Crop Protection Ag |
Process for the preparation of 2,2-difluoro-1,3-benzodioxole derivatives with sulfur containing substituents
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|